Overview of
The Bryan K. Guidizi Lung Cancer Program 

Cancer patients and their families who volunteer for Bryan's Program at ICAN will help the global oncology community shine a bright light on the fact that lung cancer can be diagnosed in never-smokers who are in excellent health, who are in top physical condition, and who've "done everything right."

ICAN’s Lung Cancer Patient Services, in cherished memory of Bryan, include:

  • A review and analysis of the patient's pathology report relating to TNM staging ("Tumor Node Metastasis"); review of the patient's medical history, lifestyle and risk factors, family history, and current condition.
  • Discussion of how co-morbid conditions or diseases could affect cancer treatment.
  • Review of symptoms prior to presentation.
  • Referrals, at the patient’s request, to medical oncologists, radiation oncologists, surgical oncologists, radiologists, interventional radiologists, neurosurgeons and neuro-oncologists, pain management specialists, and additional specialists (e.g., pulmonologists, nephrologists, endocrinologists, gastroenterologists, dermatologists) relevant to the patient's ongoing care.
  • Referrals to support groups that may be of assistance in handling the emotional impact that cancer has on the patient and the patient's family.
  • Referrals to cancer-specific organizations that may be of assistance in addressing insurance issues or employment termination issues (because of diagnosis or disclosure of metastatic disease).
  • Review of the nature/amelioration of specific side effects from chemotherapy, targeted drugs, immunotherapies, or other anticancer therapies.
  • Discussion of the interaction of diet and anticancer drugs based on recent studies.
  • Discussion of the reasons that supplements or complementary and alternative medicinal “CAM”) products may be prohibited in a clinical trial setting.
  • Delineation of the symptoms about which the patient should alert his/her oncologist.
  • Discussion of relevant imaging.
  • Discussion of pain management issues and treatment options that can be addressed with the patient's oncology team.
  • Explanation of the recommendations given or not given by the patient's physicians; assistance in answering the patient's questions which remain either after or between appointments with the medical team.
  • Review of the relevant radiation therapy/interventional radiology options which the patient, in turn, may discuss with his/her medical oncology team.
  • Review and discussion of the patient’s genomics/next-generation sequencing studies, proteomics studies, and immune cell studies to better understand the molecular characterization and resistance mechanisms of the patient’s cancer.
  • Analysis of relevant cancer clinical trials options as well as the nature and purpose of clinical trials using Remission Coach®.
  • Review of relevant cancer-specific drugs in the anticancer pipeline.
  • Review of Cyber Knife, Gamma Knife, and Whole Brain Radiation Therapy (WBRT), and craniotomy, when necessary. 
  • Discussion of LMD or leptomeningeal disease, when that is diagnosed.
  • Discussion of anticancer drugs which cross the blood-brain barrier if the patient has been diagnosed with brain metastasis.
  • Review of the available options regarding the possibility of the oncology team securing pre-approval access via a Single-Patient Clinical Protocol /compassionate use / "Right to Try" request for an appropriate anticancer drug that the patient is unable to access in a clinical trial.
  • Exploration of options that might defray airfare or hotel expenses for the patient traveling to a clinical trial.


The Bryan K. Guidizi Lung Cancer Program
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Program Advocacy Services.

For more information about this special program, please click on.....

  1. Main
  2. Photos
  3. Inspiration
  4. Memories
  5. Literature


ICAN is currently working on The Bryan K. Guidizi Lung Cancer Program. We are working to put together a Family and Friends Advisory Council for the The Bryan K. Guidizi Lung Cancer Program. If interested, please email us at Bryan.Guidizi.Program@askican.org.

If you would like to become involved as a donor and supporter or a member of our Cancer Research Literature team as a Research Team Leader (medical school students, physicians, nurses, and post-docs only please), you may reach us at Bryan.Guidizi.Program@askican.org.

Guidestar Platinum Seal of Transparency 2021

Federal Tax I.D.: EIN 86-0818253